Waiv vs MarketAxess

Side-by-side comparison of AI visibility scores, market position, and capabilities

MarketAxess leads in AI visibility (70 vs 39)
Waiv logo

Waiv

EmergingDigital Health

AI Digital Pathology & Oncology

Raised $33M seed (Mar 2026). Owkin Dx spinout. Multimodal oncology AI analyzing pathology images + clinical data for treatment decisions. Positioned against Tempus and Foundation Medicine.

AI VisibilityBeta
Overall Score
D39
Category Rank
#1 of 1
AI Consensus
52%
Trend
up
Per Platform
ChatGPT
35
Perplexity
30
Gemini
33

About

Waiv is a digital pathology AI company spun out of Owkin's diagnostic unit in March 2026 with a $33 million seed round, inheriting Owkin's proven multimodal oncology AI stack that has been validated in multiple peer-reviewed publications and clinical collaborations with major academic medical centers. The platform analyzes H&E-stained pathology slide images combined with genomic, clinical, and outcomes data to extract prognostic and predictive biomarkers that help oncologists select optimal treatments for individual cancer patients.

Full profile
MarketAxess logo

MarketAxess

LeaderConsumer Finance

Enterprise

New York electronic bond trading (NASDAQ: MKTX) $763M FY2024 revenue; Open Trading $2T+ liquidity, 40% US IG bond electronification, portfolio trading growth competing with Tradeweb and Bloomberg.

AI VisibilityBeta
Overall Score
B70
Category Rank
#13 of 290
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
65
Perplexity
65
Gemini
68

About

MarketAxess Holdings Inc. is a New York City-based electronic fixed income trading platform — publicly traded on the NASDAQ (NASDAQ: MKTX) as an S&P 500 Financials component — operating the leading electronic trading marketplace for US investment-grade corporate bonds, US high-yield bonds, emerging market bonds, municipal bonds, and US Treasury securities through approximately 850 employees globally. In fiscal year 2024, MarketAxess reported revenues of $763 million with record trading volumes in US investment-grade bonds and emerging market credit, as the multi-year electronification trend in bond markets continued to shift institutional fixed income trading from voice broker-dealer phone execution to electronic all-to-all trading on MarketAxess's Open Trading marketplace. CEO Chris Concannon (joined 2023, formerly Cboe Global Markets president) leads MarketAxess's strategy of expanding market share beyond the institutional investment-grade core into rate products (US Treasuries, agency securities), high-yield, and portfolio trading as fixed income electronification accelerates — currently approximately 40% of US investment-grade bonds trade electronically versus 15% in 2015. MarketAxess's Open Trading protocol (anonymous all-to-all price discovery between buy-side, sell-side, and market makers) generated over $2 trillion in liquidity provision in 2024, reducing transaction costs versus bilateral dealer quotes by an average of $0.28 per $100 face value.

Full profile

AI Visibility Head-to-Head

39
Overall Score
70
#1
Category Rank
#13
52
AI Consensus
79
up
Trend
stable
35
ChatGPT
65
30
Perplexity
65
33
Gemini
68
32
Claude
73
50
Grok
65

Key Details

Category
AI Digital Pathology & Oncology
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Waiv
AI Digital Pathology & Oncology
MarketAxess is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.